StockData
Prothena Corp Public Ltd Co logo

Prothena Corp Public Ltd Co (PRTA) stock

PRTANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3022% below fair value
$8.26+0.29 (+3.64%)

Close on Nov 17, 2026Market cap $424.04MP/E –Yield –

Prothena Corp Public revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Prothena Corp Public's revenue for the twelve months ending Jun 30, 2026 was $54.53M, up 427.3% year over year. For fiscal 2025 it was $9.68M, down 92.8% from the year before. Over ten years it grew 19.7% a year on average. The highest annual figure on record is $200.58M in fiscal 2021.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$9.68M-92.8%
FY2024Dec 31, 2024$135.16M+47.9%
FY2023Dec 31, 2023$91.37M+69.5%
FY2022Dec 31, 2022$53.91M-73.1%
FY2021Dec 31, 2021$200.58M+23414.3%
FY2020Dec 31, 2020$853.00K+4.8%
FY2019Dec 31, 2019$814.00K-14.8%
FY2018Dec 31, 2018$955.00K-96.5%
FY2017Dec 31, 2017$27.52M+2508.4%
FY2016Dec 31, 2016$1.06M-34.3%
FY2015Dec 31, 2015$1.61M-96.8%
FY2014Dec 31, 2014$50.85M+7422.8%
FY2013Dec 31, 2013$676.00K-74.6%
FY2012Dec 31, 2012$2.66M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.01M-77.1%
Q1 FY2026Mar 31, 2026$51.08M+1706.4%
Q4 FY2025Dec 31, 2025$21.00K-99.0%
Q3 FY2025Sep 30, 2025$2.42M+149.0%
Q2 FY2025Jun 30, 2025$4.42M-96.7%
Q1 FY2025Mar 31, 2025$2.83M+5556.0%
Q4 FY2024Dec 31, 2024$2.12M+571.8%
Q3 FY2024Sep 30, 2024$970.00K-98.9%
Q2 FY2024Jun 30, 2024$132.01M+3184.7%
Q1 FY2024Mar 31, 2024$50.00K-97.7%
Q4 FY2023Dec 31, 2023$316.00K-99.4%
Q3 FY2023Sep 30, 2023$84.87M+5494.3%
Q2 FY2023Jun 30, 2023$4.02M+206.3%
Q1 FY2023Mar 31, 2023$2.17M+88.1%
Q4 FY2022Dec 31, 2022$49.92M+4159.6%
Q3 FY2022Sep 30, 2022$1.52M-98.9%
Q2 FY2022Jun 30, 2022$1.31M-97.8%
Q1 FY2022Mar 31, 2022$1.15M+620.6%
Q4 FY2021Dec 31, 2021$1.17M+225.6%
Q3 FY2021Sep 30, 2021$139.17M+88545.9%
Q2 FY2021Jun 30, 2021$60.07M+30705.6%
Q1 FY2021Mar 31, 2021$160.00K+13.5%
Q4 FY2020Dec 31, 2020$360.00K+40.6%
Q3 FY2020Sep 30, 2020$157.00K-23.4%
Q2 FY2020Jun 30, 2020$195.00K+16.8%
Q1 FY2020Mar 31, 2020$141.00K-24.2%
Q4 FY2019Dec 31, 2019$256.00K+32.0%
Q3 FY2019Sep 30, 2019$205.00K-19.6%
Q2 FY2019Jun 30, 2019$167.00K-40.1%
Q1 FY2019Mar 31, 2019$186.00K-18.1%
Q4 FY2018Dec 31, 2018$194.00K-15.3%
Q3 FY2018Sep 30, 2018$255.00K+16.4%
Q2 FY2018Jun 30, 2018$279.00K-99.0%
Q1 FY2018Mar 31, 2018$227.00K-12.4%
Q4 FY2017Dec 31, 2017$229.00K+33.9%
Q3 FY2017Sep 30, 2017$219.00K-23.4%
Q2 FY2017Jun 30, 2017$26.81M–
Q1 FY2017Mar 31, 2017$259.00K–
Q4 FY2016Dec 31, 2016$171.00K–
Q3 FY2016Sep 30, 2016$286.00K–

More Prothena Corp Public figures

See a number that looks wrong?